Keyphrases
13-valent Pneumococcal Conjugate Vaccine (PCV13)
14%
Aac(6')-Ib-cr
19%
Bacteremia
18%
Ciprofloxacin
18%
Clinical Outcomes
18%
Community-acquired Pneumonia
31%
Confidence Interval
18%
Empiric Antibiotics
15%
Endocarditis
38%
Escherichia Coli
15%
Etiology
13%
Gyrase
14%
Hospitalized Patients
18%
Immunocompromised Patients
12%
Infectious Diseases
12%
Infective Endocarditis
98%
International Collaboration on Endocarditis
30%
Invasive Pneumococcal Disease
18%
Israel
52%
Klebsiella Pneumoniae (K. pneumoniae)
14%
KPC-2
13%
Left-sided Infective Endocarditis
21%
Odds Ratio
15%
PCV7
16%
Plasmid
20%
Plasmid-mediated Quinolone Resistance
12%
Prospective Cohort Study
38%
Quinolones
22%
Risk Factors
26%
Staphylococcus Aureus
31%
Medicine and Dentistry
Bloodstream Infection
11%
Community-Acquired Pneumonia
24%
Congestive Heart Failure
10%
COVID-19
12%
Disease
11%
Endocarditis
57%
Hazard Ratio
11%
Infection
50%
Infective Endocarditis
100%
Pathogen
15%
Pneumococcal Infection
14%
Prevalence
19%
Prospective Cohort Study
28%
Surgery
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bacterial Endocarditis
48%
Community Acquired Pneumonia
12%
Endocarditis
37%
Infection
24%
Pneumococcal Infection
14%
Prevalence
18%
Prospective Cohort Study
23%
Quinolone
13%
Staphylococcus Aureus
17%